Substance Use Disorder Billing 2026: MOUD, OTP & Mental Health Parity

Substance use disorder treatment is one of the most under-reimbursed and over-denied specialties in behavioral health. The coding is fragmented across multiple systems — HCPCS, CPT, and state-specific codes all in play at once — and parity compliance violations by insurers are routine. If you're running an SUD practice and not actively monitoring your denial rates by payer, you're almost certainly leaving money uncollected.

Here's how billing works across the main SUD service categories in 2026, and where the money tends to disappear.

MOUD: Medication for Opioid Use Disorder

MOUD is the clinical and billing category for buprenorphine, naltrexone, and methadone-based treatment. The billing model depends on the setting.

Office-Based Opioid Treatment (OBOT)

Physicians and qualified practitioners prescribing buprenorphine in an office setting bill this as a standard E/M visit — 99212 through 99215 depending on MDM complexity. The prescription itself isn't separately billable; it's part of the E/M service. Drug testing (urine drug screens) can be billed separately using 80305–80307 or G0480–G0483 depending on the methodology.

The DEA waiver requirement for buprenorphine prescribing was eliminated in 2023 under the Mainstreaming Addiction Treatment (MAT) Act. Any DEA-licensed provider can now prescribe buprenorphine without a separate waiver. That opened up prescribing significantly, but billing compliance expectations didn't relax — your documentation still needs to support the visit level you're coding.

Opioid Treatment Programs (OTPs)

OTPs — licensed facilities providing methadone and other MOUD — bill Medicare through a bundled weekly payment system using HCPCS codes. This model changed substantially in 2020 and has continued to evolve.

Medicaid OTP billing varies wildly by state — some states use the federal HCPCS structure, others have state-specific codes. If you operate in multiple states, you need payer-specific billing rules for each Medicaid program.

SBIRT: Screening, Brief Intervention, and Referral to Treatment

SBIRT is both a clinical protocol and a billing category. It's one of the most underused revenue streams in primary care and behavioral health practices.

The G-codes are primarily Medicaid. The 99408/99409 codes work for commercial and Medicare. You need to document the screening tool used (AUDIT, DAST-10, CAGE, CRAFFT for adolescents), the score, and the intervention provided. Without that, these claims deny every time.

Mental Health Parity — What It Actually Means for Billing

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that insurance plans not impose more restrictive treatment limitations on mental health and SUD benefits than they do on medical/surgical benefits. That's the law. In practice, payers violate it constantly — and most SUD providers don't push back.

What parity violations look like in billing:

• Prior auth required for SUD residential treatment when it's not required for comparable medical stays
• Session limits on outpatient SUD counseling with no equivalent limit on outpatient physical therapy
• Narrower networks for SUD treatment than for general medical care
• Stricter medical necessity criteria for SUD services than for analogous medical conditions

ASAM Criteria and Medical Necessity Documentation

The American Society of Addiction Medicine (ASAM) criteria are the clinical standard for determining the appropriate level of care in SUD treatment. Most payers use ASAM levels (0.5 through 4.0) as their medical necessity framework — even if they don't say so explicitly in their policies.

Your documentation needs to speak this language. A note that says "patient needs residential treatment" doesn't cut it. A note that documents the six ASAM dimensions — intoxication/withdrawal potential, biomedical conditions, emotional/behavioral conditions, readiness to change, relapse potential, and recovery environment — and supports the recommended level of care will hold up in an appeal.

Residential and Intensive Outpatient (IOP) Billing

References

• SAMHSA Treatment Improvement Protocol (TIP) 63 — Medications for Opioid Use Disorder
• CMS OTP Billing Guide 2026
• MHPAEA Final Rule, 2024
• ASAM Patient Placement Criteria, 3rd Edition
• DEA Buprenorphine Prescribing FAQs (post-MAT Act)